newsfilter
← Latest News
GlobeNewswire·

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we close out the